Surface modification and paclitaxel drug delivery of folic acid modified polyethylene glycol functionalized hydroxyapatite nanoparticles
Authors:
- G. Devanand VenkatasubbuGVG. Devanand Venkatasubbu
- S. RamasamySRS. Ramasamy
- G.S. AvadhaniGAG.S. Avadhani
- V. RamakrishnanVRV. Ramakrishnan
- J. KumarJKJ. Kumar
- 1 February 2013
- journal article
- Published by Elsevier in Powder Technology
- Vol. 235, 437-442
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Prolonged local antibiotics delivery from hydroxyapatite functionalised with cyclodextrin polymersBiomaterials, 2009
- Spray-dried hydroxyapatite-5-Fluorouracil granules as a chemotherapeutic delivery systemCeramics International, 2009
- Bioactive, luminescent and mesoporous europium-doped hydroxyapatite as a drug carrierBiomaterials, 2008
- A simple route to prepare stable hydroxyapatite nanoparticles suspensionJournal of Nanoparticle Research, 2008
- Exploiting the high-affinity phosphonate–hydroxyapatite nanoparticle interaction for delivery of radiation and drugsJournal of Nanoparticle Research, 2007
- Drug targeting with nano-sized carrier systemsJournal of Artificial Organs, 2005
- Surface modification of monodisperse magnetite nanoparticles for improved intracellular uptake to breast cancer cellsJournal of Colloid and Interface Science, 2005
- Targeted drug delivery via the folate receptorAdvanced Drug Delivery Reviews, 2000
- Hydroxyapatite microcarriers for biocontrolled release of protein drugsInternational Journal of Pharmaceutics, 1994
- Anticancer Effects of Adriamycin-Loaded Hydroxyapatite Implants Determined in a Swarm Rat Chondrosarcoma Model.The Japanese Journal of Pharmacology, 1994